Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27.4M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
8.22M
-
Shares change
-
-1.25M
-
Total reported value, excl. options
-
$10.2M
-
Value change
-
-$1.63M
-
Put/Call ratio
-
0.31
-
Number of buys
-
18
-
Number of sells
-
-23
-
Price
-
$1.24
Significant Holders of ICAD, INC. - Common Stock, $0.01 par value (ICAD) as of Q1 2023
57 filings reported holding ICAD - ICAD, INC. - Common Stock, $0.01 par value as of Q1 2023.
ICAD, INC. - Common Stock, $0.01 par value (ICAD) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.22M shares
of 27.4M outstanding shares and own 29.98% of the company stock.
Largest 10 shareholders include Granahan Investment Management, LLC (2.15M shares), VANGUARD GROUP INC (1.06M shares), Portolan Capital Management, LLC (911K shares), First Eagle Investment Management, LLC (741K shares), PURA VIDA INVESTMENTS, LLC (383K shares), BlackRock Inc. (371K shares), GREENWOOD CAPITAL ASSOCIATES LLC (321K shares), GEODE CAPITAL MANAGEMENT, LLC (222K shares), GENERAL AMERICAN INVESTORS CO INC (200K shares), and PERRITT CAPITAL MANAGEMENT INC (200K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.